160 related articles for article (PubMed ID: 25356506)
1. Overexpression of microRNA-30b improves adenovirus-mediated p53 cancer gene therapy for laryngeal carcinoma.
Li L; Wang B
Int J Mol Sci; 2014 Oct; 15(11):19729-40. PubMed ID: 25356506
[TBL] [Abstract][Full Text] [Related]
2. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
3. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
Wang Q; Han D; Wang W
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
[TBL] [Abstract][Full Text] [Related]
4. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1.
Zhu ED; Li N; Li BS; Li W; Zhang WJ; Mao XH; Guo G; Zou QM; Xiao B
PLoS One; 2014; 9(8):e106049. PubMed ID: 25170877
[TBL] [Abstract][Full Text] [Related]
5. DGCR5 promotes cancer stem cell-like properties of radioresistant laryngeal carcinoma cells by sponging miR-506 via Wnt pathway.
Tang T; Shan G
J Cell Physiol; 2019 Aug; 234(10):18423-18431. PubMed ID: 30980388
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.
Tian L; Zhang J; Ge J; Xiao H; Lu J; Fu S; Liu M; Sun Y
Med Oncol; 2014 Jan; 31(1):785. PubMed ID: 24297308
[TBL] [Abstract][Full Text] [Related]
8. Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma.
Koom WS; Park SY; Kim W; Kim M; Kim JS; Kim H; Choi IK; Yun CO; Seong J
J Radiat Res; 2012; 53(2):202-10. PubMed ID: 22510592
[TBL] [Abstract][Full Text] [Related]
9. Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells.
Qiu Z; Lao M; Wu C
Cancer Lett; 2001 Jun; 167(1):25-32. PubMed ID: 11323095
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of human laryngeal carcinoma growth by gene therapy and epigenetic therapy].
Lian M; Jiang LY; Wang H; Fan EZ; Wang Q; Fang JG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 47(9):753-9. PubMed ID: 23141446
[TBL] [Abstract][Full Text] [Related]
11. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
12. Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway.
Chen H; Guo Y; Huang J; Zhou L
Biomed Res Int; 2021; 2021():2342784. PubMed ID: 33791361
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1469, a p53-responsive microRNA promotes Genistein induced apoptosis by targeting Mcl1 in human laryngeal cancer cells.
Ma CH; Zhang YX; Tang LH; Yang XJ; Cui WM; Han CC; Ji WY
Biomed Pharmacother; 2018 Oct; 106():665-671. PubMed ID: 29990856
[TBL] [Abstract][Full Text] [Related]
14. Enhanced effect of recombinant adenoviruses co-expression of ING4 and OSM on anti-tumour activity of laryngeal cancer.
Cheng F; Zhao S; Li J; Niu Y; Huang H; Yang J; Ma S; Liu J; Sun P
J Cell Mol Med; 2022 Mar; 26(5):1556-1566. PubMed ID: 35075768
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin.
Bian K; Fan J; Zhang X; Yang XW; Zhu HY; Wang L; Sun JY; Meng YL; Cui PC; Cheng SY; Zhang J; Zhao J; Yang AG; Zhang R
FEBS Lett; 2012 Mar; 586(6):804-9. PubMed ID: 22306317
[TBL] [Abstract][Full Text] [Related]
16. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
17. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.
Zhong K; Chen K; Han L; Li B
BMC Cancer; 2014 Sep; 14():703. PubMed ID: 25249344
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
